Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > NML confirms MonkeyPox is of the same category

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jul 28, 2022 5:16pm

188 Views

Post# 34858315

RE:NML confirms MonkeyPox is of the same category

TLT would only need a confirmation by NML that our Theralase® anti-viral platform technology can also be effective in the destruction of this virus. No need to trial it. Just let know big pharmas about the versatility and efficiency of our platform to handle various sorts of viruses.

Versatility and efficiency; That's how BioNtech attracted Pfizer in 2018, way before COVID-19 was there. By showing how versatile would be its mRNA platform. BioNtech is now worth 37B$ and is at its 4rd vaccine collaboration with Pfizer.

<< Previous

Bullboard Posts

Next >>

How Canadian investors can benefit from flow-through shares